Rice and Baylor receive $2.8 million to suppress inflammation and lung damage in ARDS patients

Rice University and Baylor College of Medicine have received $2.8 million in funding from the National Heart, Lung, and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), for research on reducing inflammation and lung damage in acute respiratory distress syndrome (ARDS) patients.

Experimental drug shows promise in restoring memory in Alzheimer’s model

A paradigm-shifting study from the Centre for Addiction and Mental Health (CAMH) shows an experimental drug, GL-II-73, has the potential to restore memory and cognitive

February 5, 2025

New scoring system developed to recognize and reward senior doctors and dentists

A team of researchers has developed a new scoring system for a nationwide scheme, overseen by the Advisory Committee on Clinical Impact Awards (ACCIA), to

January 16, 2025

H5N1 communication has been strictly for the birds. Didn’t the federal government learn anything from Covid?

When it comes to federal agencies communicating to the public about H5N1 bird flu, it feels like a classic case of Yogi Berra’s déjà vu

May 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

​​​​​​​Rice and Baylor receive $2.8 million to suppress inflammation and lung damage in ARDS patients